Letters POPADAD trial

Author’s reply

BMJ 2008; 337 doi: http://dx.doi.org/10.1136/bmj.a2582 (Published 19 November 2008) Cite this as: BMJ 2008;337:a2582
  1. Jill Belch, professor of vascular medicine1
  1. 1Institute of Cardiovascular Research, University of Dundee, Ninewells Hospital, Dundee DD1 9SY
  1. j.j.f.belch{at}dundee.ac.uk

    We support Elwood’s suggestion to include our study in a meta-analysis of all aspirin primary prevention studies. We believe this may already be in draft form, but such an analysis, albeit without POPADAD, yielded negative results.1

    We agree that the event rate …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial